← 홈

Antibody · 림프종

169개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 169개
AntibodystaleRochePhase 2

where available (Rituximab, Rituximab (where available))

Non-hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Rituximab + MG4101 (Rituximab + MG4101)

CD20-positive Non-Hodgkin Lymphoma · CD20

#CD20#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

Rituximab - Bendamustine (Rituximab - Bendamustine)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab - CHOP (Rituximab - CHOP)

Diffuse Large B-cell Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Rituximab - CVP (Rituximab - CVP)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRocheApproved

Rituximab Fludarabine Cyclophosphamide (Rituximab Fludarabine Cyclophosphamide)

Non Hodgkin Lymphoma · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab and DexaBEAM (Rituximab and DexaBEAM)

Relapsed Non-Hodgkin-Lymphoma · Relapsed Non-Hodgkin-Lymphoma

#RelapsedNon-Hodgkin-Lymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab i.v. (Rituximab i.v.)

MALT Lymphoma · MALT Lymphoma

#MALTLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

Rituximab maintenance therapy (Rituximab maintenance therapy)

Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma · Recurrent Grade 1 Follicular Lymphoma

#RecurrentGrade1FollicularLymphom#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

Rituximab or Iodine I 131 Tositumomab Therapy (Rituximab or Iodine I 131 Tositumomab Therapy)

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab plus CHOP Immunochemotherapy (Rituximab plus CHOP Immunochemotherapy)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab s.c. (Rituximab s.c.)

MALT Lymphoma · MALT Lymphoma

#MALTLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

Rituximab+Ifosfamide+Mesna+Mitoxantrone hydrochloride liposome+Etoposide (Rituximab+Ifosfamide+Mesna+Mitoxantrone hydrochloride liposome+Etoposide)

DLBCL - Diffuse Large B Cell Lymphoma · DLBCL - Diffuse Large B Cell Lymphoma

#DLBCL-DiffuseLargeBCellLymphoma#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Rituximab+mVPDL (Rituximab+mVPDL)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab, Bendamustine, Cytarabine (Rituximab, Bendamustine, Cytarabine)

Lymphoma, Mantle-Cell · Lymphoma, Mantle-Cell

#LymphomaMantle-Cell#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

R-CHOP (Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone, Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone (R-CHOP))

Non-Hodgkin's B-cell Lymphoma; Lymphoma Non-Hodgkin · Non-Hodgkin's B-cell Lymphoma

#Non-HodgkinsB-cellLymphoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 1

Rituximab, Ifosfamide, Carboplatin, Etoposide, Bortezomib (Rituximab, Ifosfamide, Carboplatin, Etoposide, Bortezomib)

Lymphoma, B-Cell · Lymphoma, B-Cell

#LymphomaB-Cell#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

Primary CNS Lymphoma · Primary CNS Lymphoma

#PrimaryCNSLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

Rituximab, Methotrexate, and Thiotepa (R-MT, Rituximab, Methotrexate, and Thiotepa, Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation)

Primary Central Nervous System Lymphoma (PCNSL); CNS Lymphoma Treatment · Primary Central Nervous System Lymphoma

#PrimaryCentralNervousSystemLymph#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C (Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C)

B-cell Non Hodgkin Lymphoma; Mature B-cell Leukemia Burkitt-type · B-cell Non Hodgkin Lymphoma

#B-cellNonHodgkinLymphoma#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE

6 / 9 페이지

← 이전다음 →